Your browser doesn't support javascript.
loading
ErbB2 blockade with Herceptin (trastuzumab) enhances peripheral nerve regeneration after repair of acute or chronic peripheral nerve injury.
Hendry, J Michael; Alvarez-Veronesi, M Cecilia; Placheta, Eva; Zhang, Jennifer J; Gordon, Tessa; Borschel, Gregory H.
Affiliation
  • Hendry JM; Division of Plastic and Reconstructive Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Alvarez-Veronesi MC; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Placheta E; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Zhang JJ; Division of Plastic and Reconstructive Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Gordon T; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Borschel GH; Division of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria.
Ann Neurol ; 80(1): 112-26, 2016 07.
Article in En | MEDLINE | ID: mdl-27159537
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, ErbB-2 / Peripheral Nerve Injuries / Trastuzumab / Nerve Regeneration Limits: Animals Language: En Journal: Ann Neurol Year: 2016 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, ErbB-2 / Peripheral Nerve Injuries / Trastuzumab / Nerve Regeneration Limits: Animals Language: En Journal: Ann Neurol Year: 2016 Document type: Article Affiliation country: Canada Country of publication: United States